Baader Bank Aktiengesellschaft Nex Immune, Inc. Transaction History

Baader Bank Aktiengesellschaft

  • $1.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.2 - $0.3 $274 - $411
1,372 Added 8.64%
17,251 $3,000
Q2 2023

Aug 11, 2023
SELL
$0.26 - $0.47 $3,577 - $6,467
-13,761 Reduced 46.43%
15,879 $4,000
Q1 2023

May 15, 2023
BUY
$0.3 - $0.6 $8,892 - $17,784
29,640 New
29,640 $11,000

About NexImmune, Inc.

NEXI Quotes by TradingView
  • Ticker NEXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,155,600
  • Market Cap $5.07M
  • Description
  • NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...
More about NEXI
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email